Survival analysis of mortality and development of lupus nephritis in patients with systemic lupus erythematosus up to 40 years of follow-up
- PMID: 35412595
- PMCID: PMC9788815
- DOI: 10.1093/rheumatology/keac218
Survival analysis of mortality and development of lupus nephritis in patients with systemic lupus erythematosus up to 40 years of follow-up
Abstract
Objectives: Patients with SLE have increased mortality compared with age- and sex-matched controls. LN is a severe manifestation of SLE and an important cause of death. We carried out a retrospective survival analysis to investigate factors that could influence the risk of mortality and LN in a large multi-ethnic cohort of patients with SLE.
Methods: By careful review of medical records, we identified 496 patients with SLE for whom we had complete information regarding the period of observation and occurrence of death and nephritis. Patients were stratified into groups according to sex, ethnicity, age at start of follow-up and time period of diagnosis. Kaplan-Meier analysis was used to investigate differences between the groups.
Results: Of the 496 patients in the study, 91 (18.3%) died, 165 (33.3%) developed LN and 33 (6.7%) developed end-stage renal failure. There was no difference between men and women in either mortality or development of LN. Caucasian patients were significantly less likely to develop LN than other ethnic groups (P < 0.0001) but not less likely to die. Patients diagnosed before the median age of 28 years were significantly more likely to develop LN (P < 0.0001) but significantly less likely to die (P = 0.0039) during the period of observation. There has been a significant improvement in survival in patients diagnosed between 1978 and 1989 and those diagnosed between 2006 and 2011 (P = 0.019).
Conclusion: In our cohort, non-Caucasian ethnicity and younger age at diagnosis are associated with the risk of developing LN. There is evidence of improvement in survival of patients with SLE over time.
Keywords: ethnicity; lupus nephritis; mortality; survival analysis; systemic lupus erythematosus.
© The Author(s) 2022. Published by Oxford University Press on behalf of the British Society for Rheumatology.
Figures
Similar articles
-
Assessing the relative impact of lupus nephritis on mortality in a population-based systemic lupus erythematosus cohort.Lupus. 2019 Jun;28(7):818-825. doi: 10.1177/0961203319847275. Epub 2019 May 9. Lupus. 2019. PMID: 31072277
-
Systemic lupus erythematosus in three ethnic groups. XII. Risk factors for lupus nephritis after diagnosis.Lupus. 2002;11(3):152-60. doi: 10.1191/0961203302lu158oa. Lupus. 2002. PMID: 12004788
-
Risk and Factors associated with disease manifestations in systemic lupus erythematosus - lupus nephritis (RIFLE-LN): a ten-year risk prediction strategy derived from a cohort of 1652 patients.Front Immunol. 2023 Jun 15;14:1200732. doi: 10.3389/fimmu.2023.1200732. eCollection 2023. Front Immunol. 2023. PMID: 37398664 Free PMC article.
-
Systemic lupus erythematosus, lupus nephritis and end-stage renal disease: a pragmatic review mapping disease severity and progression.Lupus. 2020 Aug;29(9):1011-1020. doi: 10.1177/0961203320932219. Epub 2020 Jun 22. Lupus. 2020. PMID: 32571142 Free PMC article. Review.
-
FCGR3B copy number loss rather than gain is a risk factor for systemic lupus erythematous and lupus nephritis: a meta-analysis.Int J Rheum Dis. 2015 May;18(4):392-7. doi: 10.1111/1756-185X.12342. Epub 2014 Mar 27. Int J Rheum Dis. 2015. PMID: 24673810 Review.
Cited by
-
Dynamics of CD4+ and CD8+ Lymphocytic Inflammatory Infiltrates in Lupus Nephritis.Int J Mol Sci. 2024 Oct 7;25(19):10775. doi: 10.3390/ijms251910775. Int J Mol Sci. 2024. PMID: 39409104 Free PMC article.
-
Clinical Features and Survival Analysis of Lupus Nephritis among Patients with Systemic Lupus Erythematosus: A Three-Decade-Long Retrospective Cohort Study.Biomedicines. 2024 Sep 18;12(9):2117. doi: 10.3390/biomedicines12092117. Biomedicines. 2024. PMID: 39335630 Free PMC article.
-
Clinical and Immunological Factors Associated with the Progression of Lupus Nephritis in a Population from the Colombian Caribbean.Biomedicines. 2024 Sep 9;12(9):2047. doi: 10.3390/biomedicines12092047. Biomedicines. 2024. PMID: 39335560 Free PMC article.
-
Urinary Biomarkers for Lupus Nephritis: A Systems Biology Approach.J Clin Med. 2024 Apr 18;13(8):2339. doi: 10.3390/jcm13082339. J Clin Med. 2024. PMID: 38673612 Free PMC article. Review.
-
Management and treatment of children, young people and adults with systemic lupus erythematosus: British Society for Rheumatology guideline scope.Rheumatol Adv Pract. 2023 Dec 5;7(3):rkad093. doi: 10.1093/rap/rkad093. eCollection 2023. Rheumatol Adv Pract. 2023. PMID: 38058676 Free PMC article. Review.
References
-
- Yurkovich M, Vostretsova K, Chen W, Avina-Zubieta JA.. Overall and cause-specific mortality in patients with systemic lupus erythematosus: a meta-analysis of observational studies. Arthritis Care Res 2014;66:608–16. - PubMed
-
- Tektonidou MG, Lewandowski LB, Hu J, Dasgupta A, Ward MM.. Survival in adults and children with systemic lupus erythematosus: a systematic review and Bayesian meta-analysis of studies from 1950 to 2016. Ann Rheum Dis 2017;76:2009–16. - PubMed
-
- Bernatsky S, Boivin JF, Joseph L. et al. Mortality in systemic lupus erythematosus. Arthritis Rheum 2006;54:2550–7. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical